• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25REC W/RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25REC W/RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX25REC
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 08/22/2022
Event Type  Injury  
Manufacturer Narrative
(b)(4).
 
Event Description
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, there was thrombus formation in the hardshell reservoir.Per facility, during bypass the perfusionist noticed thrombin forming in the hardshell reservoir.She then changed the reservoir out, not the oxy, and put a new hardshell reservoir in and the cases was finished with no other issues.Procedure: septal defect procedure - asd, tricuspid valve position - repair , there was a minute delay in the procedure, there was approximately 400 ml of blood loss, the product was changed out, the surgery was completed successfully, the patient is fine after the procedure.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on september 12, 2022.Upon further investigation of the reported event, the following information is new and/or changed: h6 (identification of evaluation codes 10,3331,213 ,67).Type of investigation #1: 10 - testing of actual/suspected device.Type of investigation #2: 3331 - analysis of production records.Investigation finding: 213 - no device problem found.Investigation conclusions: 67 - no problem detected.The returned sample was inspected upon receipt with some clotting noted within the reservoir.It was set up for cr and vr defoaming testing.The cr defoaming test was set up and blood was flowed at 5 lpm with air introduced into the suction ports at approximately 100ml/min for one hour.The unit was observed for foaming at 15-minute intervals for 1 hour.There was no foaming observed.Next the vr defoaming test was set up and blood was flowed at 8 lpm with air introduced into the venous inlet at approximately 100ml/min for one hour.The unit was observed for foaming after the first 5 minutes and 60 minutes, which is the end of test.There was no foaming or clotting observed.The unit was found to function as intended; therefore, a definitive root cause could not be determined.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Event Description
Additional information as per the clinical specialist that, this complaint involved the reservoir of a fx25 oxygenator that had thrombin form on it approximately one hour into cardiopulmonary bypass.A pump record was provided that revealed adequate act values during the pump run and additional administrations of heparin.A hepcon value was taken prebypass that was adequate for bypass; however no other hepcon values were taken during bypass.From the information provided from the clinician, it appears that the patient either had some heparin resistance or something else going on that affected the ability to adequately anticoagulate the patient¿s blood.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERILE FX25REC W/RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer (Section G)
SAME
Manufacturer Contact
jamie quinlan
125 blue ball road
elkton, MD 21921
8002837866
MDR Report Key15402884
MDR Text Key299701476
Report Number1124841-2022-00151
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier00699753450820
UDI-Public(01)00699753450820
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K151791
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/12/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number3CX*FX25REC
Device Catalogue NumberN/A
Device Lot NumberZN29R
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/26/2022
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received01/02/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age53 YR
Patient Weight104 KG
-
-